Exchange: NASDAQ·Updated 05:19 PM EDT
Upcoming Earnings: Q2 '26

Reports: Aug 11After Hours

Estimated EPS

-$0.20

Estimated Rev

$1.38M

$NSPR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.16 up 27.27% YoY • Reported revenue of $3.4M up 122.24% YoY • InspireMD anticipates FDA approval for its original CGuard delivery system in Q3 2026 and CGuard Prime 80 cm for TCAR procedures in H2 2026, potentially doubling its addressable market.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
-$0.20
--
--
N/A
Q1 '26
-$0.18
-$0.16
11.11%
BEAT
Q4 '25
-$0.19
-$0.14
27.59%
BEAT
Q3 '25
-$0.19
-$0.17
12.82%
BEAT
Q2 '25
-$0.26
-$0.26
--
EXPECTED

Advertisement|Remove ads.